Photos: 

Evaluation reports are either openly accessible via pdf download, or accessible via MSF's internal Sharepoint, which is mainly due to the sensitive nature of the operational contexts and resulting content. However, there are ongoing discussions about making all evaluation reports publicly searchable. If you are an MSF association member, reports are made available on various associate platforms such as www.insideOCB.com.

Topic

Country/Region

C

This survey investigates patients’ coping mechanisms and their dependence on medical institutions both from the patients’ standpoint and from that of MSF’s project teams.

Marc Le Pape and Suzanne Bradol
08/07/2015

Through an analysis of the events that have marked MSF’s history since 2003, this series of case studies and historical accounts describes the evolution of MSF's humanitarian ambitions, the resistance to these ambitions and the political arrangements that overcame this resistance (or that failed to do so).

edited by Claire Magone, Michaël Neuman, Fabrice Weissman
22/11/2011

The evaluation looks at the process for managing MSF-OCP's construction/rehabilitation projects since 2012. The main problems identified are not related to the process itself, but the way it is put into application. The main users pointed out the long delays (periods of indicision) as being the biggest difficulty, followed by budget/cost issues (cost/m² estimates) , and the quality of constructions (techniques, materials, etc). One of the root causes of delays relates to unclear/incomplete definition of roles and responsibilities = actions to take.

Nicolas Bérubé & Vincent Brown
16/07/2015

MSF has been present in the Nchelenge region since 1998, when a program was started to provide health care to Angolan and Congolese refugees who had arrived in the region. The MSF project in Nchelenge District was started in April 2001 because of lack of access to HIV/AIDS care in an area with an HIV prevalence estimated at 16.5%. The objective was to achieve a high coverage of treatment and care, and at the same time provide a model for decentralised programs to bring HIV/AIDS treatment and care to all people in Zambia and for MSF Holland/OCA more widely.

Kamalini Lokuge, Robert Musopole and Mupundu Banda
01/02/2010

This report summarises the key lessons learned from MSF's cholera interventions in Zambia 2004, 2006, 2008, 2010 (OCBA), Guinea Bissau 2005-2008 (OCBA), Juba 2006 (OCBA), Haiti 2010-2011 (OCBA), Angola 2006 (OCB, OCA, OCBA), Zimbabwe 2009 (OCB, OCA, OCBA)

M Iscla
09/05/2012

The Bosnia programme was one of the largest programmes MSF has implemented so far, and it was the first major operation MSF executed in an European environment. There was a widely shared view that the programme had gone “out of control”. As a result, many within MSF considered drug distribution in general as being beyond the scope of MSF. The dominance of drug distribution in the programme was perceived to be in contradiction with the medical identity of MSF.

Van de Putte, B. and Maslesa, L.
01/04/1998

This evaluation is an end of project cycle evaluation. The main purposes, as with all evaluations in MSF-H, are learning and accountability. While the project was initiated with a three year time line, certain activities may continue for the coming two years. The conclusions and results of this evaluation will be used as a guide for future medical programming.

Cunningham, D.
01/04/2000

RIDER, CRASH and Epicentre have finalized a critical review of the operations of MSF France in Borno, Nigeria, from 2015 to 2016.

***English and French version available***

This publication was produced by RIDER, CRASH and Epicentre.
01/03/2019

After seven years of existence and shortly before its closure, Cell 2 and the Direction of Operations launched a lessons-learned exercise of the Cardiovascular Emergency Project set at Hospital No. 9 in Grozny, Chechnya. The objective of this review was to relate the main steps and lessons of this so-called "atypical" medical project, at least in the light of MSF's experience, mobilizing a high-tech clinical expertise such as thrombolysis and angiography.

***English and French version available***

This publication was produced by MSF OCP, Cell2, in cooperation with RIDER.
01/03/2019

Pages